Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease

Sameem AbedinBlood & Marrow Transplantation and Cellular Therapy Program, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

Mehdi HamadaniBlood & Marrow Transplantation and Cellular Therapy Program, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USACorrespondence[email protected]

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (5)

Camila Derminio Donadel, Bruno Garcia Pires, Nathália Cristine André, Thalita Cristina Mello Costa, Maristela Delgado Orellana, Sâmia Rigotto Caruso, Adriana Seber, Valéria Cortez Ginani, Alessandra Araújo Gomes, Yana Novis, George Maurício Navarro Barros, Neysimélia Costa Vilella, Gláucia Helena Martinho, Ana Karine Vieira, Andrea Tiemi Kondo, Nelson Hamerschlak, Jayr Schmidt Filho, Erick Menezes Xavier, Juliana Folloni Fernandes, Vanderson Rocha, Dimas Tadeu Covas, Rodrigo Tocantins Calado, Renato Luiz Guerino-Cunha & Gil Cunha De Santis. (2023) Umbilical Cord Mesenchymal Stromal Cells for Steroid-Refractory Acute Graft-versus-Host Disease. Pharmaceuticals 16:4, pages 512.
Crossref

Adrianna Spałek, Agata Wieczorkiewicz-Kabut, Anna Koclęga, Krzysztof Woźniczka, Patryk Węglarz, Kinga Boral, Dariusz Kata, Patrycja Zielińska & Grzegorz Helbig. (2022) Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience. International Journal of Hematology 116:6, pages 922-928.
Crossref

Mélanie Hinterlang, Maria Sebti, Camille Cotteret, Fabrice Vidal, Bénédicte Neven, Salvatore Cisternino & Joël Schlatter. (2022) Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease. The Scientific World Journal 2022, pages 1-6.
Crossref

Laura F. Newell & Shernan G. Holtan. (2021) Acute GVHD: think before you treat. Hematology 2021:1, pages 642-647.
Crossref

Arthur E. Frankel, Renuka Reddy, Kayla R. DeSuza, Khaled Deeb, Aaron F. Carlin, Davey Smith, Yushuang Xie, Eknath Naik, Richard T. Silver & Hans C. Hasselbalch. (2021) Response to pegylated interferon in a COVID‐19–positive elderly woman with primary myelofibrosis treated with ruxolitinib. Clinical Case Reports 9:4, pages 2228-2235.
Crossref

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease

Articles from other publishers (5)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease

Citations (5)

Articles from other publishers (5)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date